|
UPT. PERPUSTAKAAN
Universitas Esa Unggul
Kampus Emas UEU - Jakarta Barat
|
Phone |
: |
021-5674223, ext 282 |
Fax |
: |
|
E-mail |
: |
[email protected] |
Website |
: |
http://library.esaunggul.ac.id
|
Support (Customer Service) :
|
[email protected] |
|
|
Welcome..guys!
|
Have a problem with your access?
Please, contact our technical support below:
|
LIVE SUPPORT
Astrid Chrisafi
|
! ATTENTION !
To facilitate the activation process, please fill out the member application form correctly and completely
Registration activation of our members will process up to max 24 hours (confirm by email). Please wait patiently
Still Confuse?
Please read our User Guide
|
|
UEU » Journal » Farmasi Posted by [email protected] at 15/08/2021 00:49:44 • 659 Views
SARS-COV-2: VIROLOGI DAN TARGET OBATSARS-Cov-2: Virology and Drug TargetsCreated by :
Aprilita Rina Yanti Eff ( 0318046802 )
Subject: | PANDEMI OBAT COVID-19 | Alt. Subject : | PANDEMIC DRUG CORONAVIRUS | Keyword: | SARS-COV-2 ANTIVIRUS |
Description:
Pandemi COVID-19 yang disebabkan oleh coronavirus 2 (SARS-CoV-2) menimbulkan
tantangan bagi para peneliti dalam mengidentifikasi obat yang efektif untuk pencegahan
maupun pengobatan Covid-19. Pengetahuan yang berkembang pesat mengenai virologi
SARS-CoV-2 memberikan informasi sejumlah besar target obat yang potensial. Banyak terapi
telah dilaporkan efektif menghambat replikasi SARS-CoV-2 sejak merebaknya pandemi ini.
Target utama pada obat-obat ini adalah protein esensial dalam siklus hidup virus. Beberapa
obat saat ini direkomendasikan untuk pasien COVID-19 yang memiliki gejala sedang hingga
berat, termasuk obat antivirus Favipiravir, Remdesivir, Baricitinib dan Kortikosteroid.
Pendekatan saat ini untuk terapi COVID-19 umumnya terbagi dalam dua kategori: antivirus
yang mencegah virus bereplikasi dan imunomodulator yang membantu sistem kekebalan
untuk melawan virus. Pandemi Covid-19 merupakan tantangan dan krisis kesehatan global.
Oleh karena itu sangat dibutuhkan kecepatan dan jumlah uji klinis obat-obat yang potensial
untuk Covid-19. Sampai saat ini belum ada terapi yang terbukti efektif dalam mengobati
covid-19.
Alt. Description
COVID-19 pandemic caused by coronavirus 2 (SARS-CoV-2) poses challenges for
researchers in identifying effective drugs for the prevention and treatment of COVID-19. The
rapidly growing knowledge of the virology of SARS-CoV-2 provides large number of
potential drug targets information. Many therapies have been reported to be effective at
inhibiting SARS-CoV-2 replication since the outbreak of this pandemic. The main targets of
these drugs are proteins essential in the viral life cycle. Several medications are currently
recommended for COVID-19 patients with moderate to severe symptoms, including the
antiviral drugs favipiravir, remdesivir, baricitinib, and corticosteroids. Current approaches to
COVID-19 therapy generally fall into two categories: antivirals that prevent the virus from
replicating and immunomodulators that help the immune system fight the virus. The Covid-19
pandemic is a global health challenge and crisis. Therefore, the speed and number of clinical
trials of potential drugs for Covid-19 are urgently needed. So far, no therapy is effective in
treating COVID-19.
Date Create | : | 15/08/2021 | Type | : | Text | Format | : | pdf | Language | : | Indonesian | Identifier | : | UEU-Journal-11_1821 | Collection ID | : | 11_1821 |
Source : Archives Pharmacia Volume 3 Nomor 2, Juli 2021
Relation Collection: Civitas Akademika Universitas Esa Unggul
Coverage : Fakultas Ilmu-Ilmu Kesehatan
Rights : @2021 Perpustakaan Universitas Esa Unggul
Publication URL : https://digilib.esaunggul.ac.id/sarscov2-virologi-dan-target-obat-21129.html
[ Free Download - Free for All ]
- UEU-Journal-21129-11_1821.pdf - 676 KB
[ FullText Content - Please, register first ]
...No Files...
10 Similar Document...
No similar subject found !
10 Related Document...
|
POLLINGBagaimana pendapat Anda tentang repository kami ?
Visitors Today : 1
Total Visitor : 1970146
Hits Today : 22957
Total Hits : 159201419
Visitors Online: 1
Calculated since 16 May 2012
You are connected from 172.17.121.29 using Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; [email protected])
|